Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Plos One|August 21, 2020
Tocilizumab and steroid treatment in patients with COVID-19 pneumoniaMalgorzata Mikulska, Laura Ambra Nicolini, Alessio Signori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2020
Cladribine vs other drugs in MS: Merging randomized trial with real-life dataAlessio Signori, Francesco Saccà, Roberta Lanzillo, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 studyMichele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.
Leukemia|August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance studyElena Crisà, Elvira Mora, Ulrich Germing, et al.
Iscience|October 20, 2023
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysisShobana Anpalakhan, Alessio Signori, Alessio Cortellini, et al.
Therapeutic Advances in Medical Oncology|May 28, 2021
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experienceChiara Zecca, Francesca Bovis, Giovanni Novi, et al.
Annals of Medicine|June 14, 2025
Mortality of <i>Pneumocystis jirovecii</i> pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Pageof 30